Panamed Corp.

As of July 14, 2005, Panamed Corporation was acquired by Visual Board Books, Inc. in a reverse merger transaction. Panamed Corporation engages in the bio-tech industry, with a primary focus on testing and distributing a patented line of therapeutics offered by Havel Investments Limited. The therapeutics are used for treating serious illness, such as HIV/AIDS, herpes, shingles, cancer, ALS, lupus, Parkinson's Disease, rheumatoid arthritis, and multiple sclerosis. The company has an exclusive license to test and distribute Havel's treatments for HIV/AIDS within the continent of Africa. Viro-Net is the name given to Havel's product for treating HIV/AIDS, Herpes Simplex 1, Herpes Simplex 2, and Shingles. The therapeutics can be described as an immuno-modulating biological compound, which can be used to target the virus for elimination by the body's own immune system.